Ozmosi | Bambuterol Drug Profile
Contact Us
Drug Profile
Using advanced filters...
Advanced Search [+]

Bambuterol

Alternative Names: bambuterol
Clinical Status: Inactive
Latest Update: 2015-03-17
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRB Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Austria | Bangladesh | Brazil | Chile | Colombia | Egypt | France | Germany | Hong Kong | India | Ireland | Italy | Korea | Mexico | New Zealand | Pakistan | Peru | Philippines | Portugal | Spain | Sri Lanka | Sweden | Taiwan | Thailand | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Company: Dongguan Kaifa Biopharmaceutical Co., Ltd./Hainan Zhongyu Pharmaceutical Co., Ltd.
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Bambuterol

Countries in Clinic: China

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

CTR20244653

 CTR20244653

P2

Recruiting

Unknown

None

2025-04-29

Patient Enrollment|Treatments

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions